- Home
- JILL vs OSUR Comparison
JILL vs OSUR Comparison
Compare JILL & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JILL
- OSUR
- Stock Information
- Founded
- JILL 1959
- OSUR 2000
- Country
- JILL United States
- OSUR United States
- Employees
- JILL N/A
- OSUR N/A
- Industry
- JILL Clothing/Shoe/Accessory Stores
- OSUR Medical/Dental Instruments
- Sector
- JILL Consumer Discretionary
- OSUR Health Care
- Exchange
- JILL Nasdaq
- OSUR Nasdaq
- Market Cap
- JILL N/A
- OSUR 223.0M
- IPO Year
- JILL 2017
- OSUR 1986
- Fundamental
- Price
- JILL $15.82
- OSUR $2.60
- Analyst Decision
- JILL Strong Buy
- OSUR Hold
- Analyst Count
- JILL 5
- OSUR 2
- Target Price
- JILL $36.20
- OSUR $5.50
- AVG Volume (30 Days)
- JILL 84.3K
- OSUR 444.5K
- Earning Date
- JILL 06-06-2025
- OSUR 05-07-2025
- Dividend Yield
- JILL 1.44%
- OSUR N/A
- EPS Growth
- JILL 3.98
- OSUR N/A
- EPS
- JILL 2.61
- OSUR N/A
- Revenue
- JILL $610,857,000.00
- OSUR $161,626,000.00
- Revenue This Year
- JILL $3.91
- OSUR N/A
- Revenue Next Year
- JILL $3.30
- OSUR $7.55
- P/E Ratio
- JILL $5.84
- OSUR N/A
- Revenue Growth
- JILL 0.46
- OSUR N/A
- 52 Week Low
- JILL $14.37
- OSUR $2.69
- 52 Week High
- JILL $40.61
- OSUR $5.59
- Technical
- Relative Strength Index (RSI)
- JILL 45.10
- OSUR 30.12
- Support Level
- JILL $14.64
- OSUR $2.91
- Resistance Level
- JILL $16.12
- OSUR $3.09
- Average True Range (ATR)
- JILL 0.61
- OSUR 0.11
- MACD
- JILL 0.23
- OSUR -0.02
- Stochastic Oscillator
- JILL 79.67
- OSUR 26.47
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.